Articles from EO Care, Inc.

EO Care, Inc., a leading provider of clinically guided cannabinoid-based symptom management, today announced the appointment of William Fleming, PharmD, and Kristi Savacool to its Board of Directors. Both join as directors and investors, further strengthening the company’s governance, strategic depth, and national influence as cannabinoid care advances into mainstream healthcare delivery.

EO Care, Inc., the leader in cannabinoid-based symptom management, released data using PROMIS* measures showing that patients leveraging its guided cannabinoid products and care platform reported meaningful improvements for pain, sleep, anxiety, and nausea/vomiting**.

EO Care, Inc., the leader in cannabinoid-based symptom management, today announced the launch of the next generation of its cannabinoid care platform. For the first time, older adults seeking relief for pain, stress and sleep issues and those who are seeking relief for cancer-related symptoms will have free access to EO’s clinically responsible and personalized product, dose and use guidance recommendations.